Bicara Therapeutics Inc (BCAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -111,647 | -56,211 | -137,950 | -100,564 | -64,234 |
| Depreciation Amortization | 663 | 382 | 406 | 94 | 38 |
| Other Working Capital | 14,624 | 12,190 | 14,809 | 6,367 | 3,204 |
| Other Operating Activity | 14,646 | 6,131 | 15,901 | 11,155 | 7,292 |
| Operating Cash Flow | $-81,714 | $-37,508 | $-106,834 | $-82,948 | $-53,700 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 161,000 | 101,000 | N/A | N/A | N/A |
| PPE Investments | -120 | -60 | -280 | -42 | N/A |
| Purchase Of Investment | -244,929 | N/A | -318,173 | -236,079 | N/A |
| Investing Cash Flow | $-84,049 | $100,940 | $-318,453 | $-236,121 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 165,677 | 163,345 | 32,261 | 1,031 | 595 |
| Financing Cash Flow | $165,677 | $163,345 | $32,261 | $1,031 | $595 |
| Beginning Cash Position | 96,685 | 96,685 | 489,711 | 489,711 | 489,711 |
| End Cash Position | 96,599 | 323,462 | 96,685 | 171,673 | 436,606 |
| Net Cash Flow | $-86 | $226,777 | $-393,026 | $-318,038 | $-53,105 |
| Free Cash Flow | |||||
| Operating Cash Flow | -81,714 | -37,508 | -106,834 | -82,948 | -53,700 |
| Capital Expenditure | -120 | -60 | -280 | -42 | 0 |
| Free Cash Flow | -81,834 | -37,568 | -107,114 | -82,990 | -53,700 |